Loading stock data…
HNGE
$45.43+0.83 (+1.86%)
Market ClosedLast close May 1
Hinge Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Hinge Health, Inc. in the Healthcare sector is trading at $45.43. The stock is currently 27% below its 52-week high of $62.18, remaining 3.1% below its 200-day moving average. Technical signals show overbought RSI of 80 and bullish MACD crossover, explaining why HNGE maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 80) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$45.43
Potential Upside
5%
Whystock Fair Value$47.70
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus15 analysts
Buy
Mean target$57.53+26.6%
Range$43.00 – $72.00
Fundamentals
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical reha...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.53B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-140.29%
Volume
Today's trading volume
585,896
Recent News
Enhanced Group: Sports-Media and Wellness Platform Set for Rapid Scaling and Margin Inflection – Initiation Report
Download the Complete Report Here By Rayk Riechmann With this innovator set to go public investors will get access to a fresh opportunity at the intersection of sports entertainment monetization and performance-wellness product distribution. Enhanced Ltd. is getting ready to enter public markets through a business combination with A Paradise Acquisition Corp. (Nasdaq: APAD). Following […]
Insider-Favored Growth Stocks Including Pagaya Technologies
The United States market has shown robust performance with a 3.4% climb in the last week and a 35% increase over the past year, while earnings are anticipated to grow by 16% annually in the coming years. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business, potentially aligning well with investor interests.
Director Sells 50,000 Shares of Digital Health Platform Stock for $1.9 Million, According to Recent SEC Filing
This digital health platform for musculoskeletal care reported significant insider selling, according to recent SEC filings.
Hinge Health Expands Public Sector Footprint As Valuation Signals Possible Upside
Hinge Health (NYSE:HNGE) is expanding its musculoskeletal, or MSK, care programs to employees in 24 state health plans. The company now serves over 300 public sector organizations across the United States. Public clients include state governments and institutions such as the State of Maine and Texas A&M University System. Hinge Health focuses on digital MSK care, an area that sits at the intersection of healthcare, employee benefits and technology. As more employers and public agencies look...
Here's Why You Should Add Hinge Health Stock to Your Portfolio Now
HNGE pairs rapid growth and AI-driven efficiency with rising execution risks as 2026 slowdown, margin pressure, and engagement reliance cloud outlook.